COLLIER ALAN BRIAN (CEO) purchased 0.2% of their position (52K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $635.50 — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+11K
Price / share
$0.01
Trade value
$130.90
% of position
Common Stock
Shares
+11K
Price / share
$0.01
Trade value
$133.10
% of position
Common Stock
Shares
+11K
Price / share
$0.01
Trade value
$134.20
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$25.80
% of position
Common Stock
Shares
+5K
Price / share
$0.01
Trade value
$62.00
% of position
Common Stock
Shares
+5K
Price / share
$0.01
Trade value
$62.50
% of position
Common Stock
Shares
+5K
Price / share
$0.01
Trade value
$62.00
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$25.00
% of position
Net shares
+52K
Net value
$635.50
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2019 | P · Purchase | +11K | $0.01 | $130.90 | 0.0% | 24.30M | 24.31M |
| Common Stock Direct | 6/13/2019 | P · Purchase | +11K | $0.01 | $133.10 | 0.0% | 24.31M | 24.32M |
| Common Stock Direct | 6/14/2019 | P · Purchase | +11K | $0.01 | $134.20 | 0.0% | 24.32M | 24.34M |
| Common Stock Direct | 6/17/2019 | P · Purchase | +2K | $0.01 | $25.80 | 0.0% | 24.34M | 24.34M |
| Common Stock Direct | 6/17/2019 | P · Purchase | +5K | $0.01 | $62.00 | 0.0% | 24.34M | 24.34M |
| Common Stock Direct | 6/17/2019 | P · Purchase | +5K | $0.01 | $62.50 | 0.0% | 24.34M | 24.35M |
| Common Stock Direct | 6/17/2019 | P · Purchase | +5K | $0.01 | $62.00 | 0.0% | 24.35M | 24.35M |
| Common Stock Direct | 6/17/2019 | P · Purchase | +2K | $0.01 | $25.00 | 0.0% | 24.35M | 24.35M |
| Total | +52K | $635.50 | ||||||